Therapeutic treatments for blood cell deficiencies

Details for Australian Patent Application No. 2008255138 (hide)

Owner Harbor Biosciences, Inc.

Inventors Prendergast, Patrick T.; Frincke, James Martin; Reading, Christopher L.

Agent Griffith Hack

Pub. Number AU-B-2008255138

Parent 2005237117

Filing date 4 December 2008

Wipo publication date 8 January 2009

Acceptance publication date 24 February 2011

International Classifications

A61K 31/00 (2006.01)

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/19 (2006.01)

A61K 31/198 (2006.01)

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/568 (2006.01) - substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone

A61K 31/739 (2006.01) - Lipopolysaccharides

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 33/14 (2006.01) Medicinal preparations containing inorganic active ingredients - Alkali metal chlorides

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

C07J 17/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton

C07J 73/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms

Event Publications

8 January 2009 Application Open to Public Inspection

  Published as AU-B-2008255138

8 January 2009 Complete Application Filed

15 January 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Dec 2008

10 June 2010 Alteration of Name

  The name of the applicant has been altered to Harbor Biosciences, Inc.

24 February 2011 Application Accepted

  Published as AU-B-2008255138

23 June 2011 Standard Patent Sealed

15 September 2011 Alteration of Name

  The name of the patentee has been altered to Harbor BioSciences, Inc.

20 October 2011 Corrigenda

  Amendments - Amendments Made Under the name Harbor BioSciences, Inc., Application No. 2008255138, delete all reference to.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008255139-Pharmaceutical composition comprising arsenite for the treatment of malignancy

2008255137-Process for obtaining a concentrate of Von Willebrand Factor or a complex of factor VIII/Von Willebrand Factor and use of the same